rs121908403
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 10P and 2B. PP3_ModeratePP5_Very_StrongBS1_SupportingBS2_Supporting
The NM_021102.4(SPINT2):āc.488A>Gā(p.Tyr163Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000197 in 1,612,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 33)
Exomes š: 0.00020 ( 0 hom. )
Consequence
SPINT2
NM_021102.4 missense
NM_021102.4 missense
Scores
9
9
1
Clinical Significance
Conservation
PhyloP100: 4.39
Genes affected
SPINT2 (HGNC:11247): (serine peptidase inhibitor, Kunitz type 2) This gene encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. The protein inhibits HGF activator which prevents the formation of active hepatocyte growth factor. This gene is a putative tumor suppressor, and mutations in this gene result in congenital sodium diarrhea. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.874
PP5
Variant 19-38290215-A-G is Pathogenic according to our data. Variant chr19-38290215-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 5205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-38290215-A-G is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.000203 (296/1460170) while in subpopulation NFE AF= 0.000254 (282/1112002). AF 95% confidence interval is 0.000229. There are 0 homozygotes in gnomad4_exome. There are 139 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 21 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPINT2 | NM_021102.4 | c.488A>G | p.Tyr163Cys | missense_variant | 5/7 | ENST00000301244.12 | NP_066925.1 | |
SPINT2 | NM_001166103.2 | c.317A>G | p.Tyr106Cys | missense_variant | 4/6 | NP_001159575.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPINT2 | ENST00000301244.12 | c.488A>G | p.Tyr163Cys | missense_variant | 5/7 | 1 | NM_021102.4 | ENSP00000301244 | P1 | |
ENST00000651064.1 | n.533-9T>C | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
21
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251384Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135884
GnomAD3 exomes
AF:
AC:
52
AN:
251384
Hom.:
AF XY:
AC XY:
26
AN XY:
135884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000203 AC: 296AN: 1460170Hom.: 0 Cov.: 31 AF XY: 0.000191 AC XY: 139AN XY: 726394
GnomAD4 exome
AF:
AC:
296
AN:
1460170
Hom.:
Cov.:
31
AF XY:
AC XY:
139
AN XY:
726394
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74350
GnomAD4 genome
AF:
AC:
21
AN:
152208
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
37
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Congenital secretory sodium diarrhea 3 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The SPINT2 c.488A>G p.(Tyr163Cys) missense variant has been identified in individuals with a phenotype consistent with (Heinz-Erian et al. 2009; Sivagnanam et al. 2010; Slae et al. 2013; Salomon et al. 2014; d'Apolito et al. 2015). The highest frequency of this allele in the Genome Aggregation Database is 0.0004337 in the European (non-Finnish) population (version 2.1.1). Heinz-Erian et al. (2009) demonstrated a significant decrease in the ability of the p.Tyr163Cys variant protein to inhibit trypsin as compared to wild type when transiently transfected in COS7 cells, and studies in Xenopus oocytes by Faller et al. (2014) showed a complete loss of inhibitory activity by the p.Tyr163Cys variant protein on two proteases, which may ultimately lead to excessive proteolytic activity. Based on the available evidence, the c.488A>G p.(Tyr163Cys) variant is classified as pathogenic for syndromic congenital diarrhea. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2014 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 12, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 163 of the SPINT2 protein (p.Tyr163Cys). This variant is present in population databases (rs121908403, gnomAD 0.04%). This missense change has been observed in individuals with congenital sodium diarrhea (PMID: 19185281, 30445423). ClinVar contains an entry for this variant (Variation ID: 5205). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SPINT2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SPINT2 function (PMID: 19185281, 30445423). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;T;.;.
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;.;.;.
MutationTaster
Benign
A;A;A
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;D;.
REVEL
Uncertain
Sift
Pathogenic
D;.;D;.
Sift4G
Pathogenic
D;D;D;D
Polyphen
D;.;.;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at